AI Insights · Timothy · January 2024
Top 5 Science Games on Android in the US: Q4 2023 Performance
Explore the download, revenue, and active user trends of the top five science games on the Android platform in the United States during Q4 2023.
During the fourth quarter of 2023, the top five science games on the Android platform in the United States exhibited notable performance trends in downloads, revenue, and weekly active users. Here's a closer look at each of these leading applications based on data from Sensor Tower.
Plague Inc. saw significant growth in both downloads and revenue. Downloads peaked at approximately 19K in the week of November 20, while revenue reached around $10K in the final week of December. Weekly active users steadily increased, peaking at about 42K in the third week of November before stabilizing around 31K towards the end of the quarter.
Cell to Singularity: Evolution experienced varied trends. Revenue fluctuated, peaking at nearly $8.7K in mid-November. Downloads remained relatively stable, with a slight uptick to 2.8K in the last week of December. Weekly active users saw a gradual decline, starting at 24.3K in late September and decreasing to approximately 21K by the end of December.
Jetpack Joyride showed a steady performance in downloads and active users. Downloads peaked at 8.5K in early November, while weekly active users remained around the 50K mark throughout the quarter. Revenue saw modest increases, reaching up to $1.9K in mid-December.
Cell Expansion Wars had a stable but low-key quarter. Revenue was modest, peaking at around $1K in late October, while weekly active users gradually declined from 758 in late September to 417 by the end of December.
Little Alchemy 2 exhibited consistent performance in downloads and active users. Downloads fluctuated, peaking at 8.9K in mid-November. Weekly active users varied, reaching a high of 21.3K in the week of November 13. Revenue remained modest, with a peak of $432 in late November.
For more detailed insights and data, visit Sensor Tower.